Cargando…

Dengue infections in non-immune travellers to Thailand

Dengue is the most frequent arboviral disease and is expanding geographically. Dengue is also increasingly being reported in travellers, in particular in travellers to Thailand. However, data to quantify the risk of travellers acquiring dengue when travelling to Thailand are lacking. Using mathemati...

Descripción completa

Detalles Bibliográficos
Autores principales: MASSAD, E., ROCKLOV, J., WILDER-SMITH, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539241/
https://www.ncbi.nlm.nih.gov/pubmed/22651899
http://dx.doi.org/10.1017/S0950268812000507
_version_ 1782255062791225344
author MASSAD, E.
ROCKLOV, J.
WILDER-SMITH, A.
author_facet MASSAD, E.
ROCKLOV, J.
WILDER-SMITH, A.
author_sort MASSAD, E.
collection PubMed
description Dengue is the most frequent arboviral disease and is expanding geographically. Dengue is also increasingly being reported in travellers, in particular in travellers to Thailand. However, data to quantify the risk of travellers acquiring dengue when travelling to Thailand are lacking. Using mathematical modelling, we set out to estimate the risk of non-immune persons acquiring dengue when travelling to Thailand. The model is deterministic with stochastic parameters and assumes a Poisson distribution for the mosquitoes' biting rate and a Gamma distribution for the probability of acquiring dengue from an infected mosquito. From the force of infection we calculated the risk of dengue acquisition for travellers to Thailand arriving in a typical year (averaged over a 17-year period) in the high season of transmission. A traveller arriving in the high season of transmission and remaining for 7 days has a risk of acquiring dengue of 0·2% (95% CI 0·16–0·23), whereas the risk for travel of 15 and 30 days' duration is 0·46% (95% CI 0·41–0·50) and 0·81% (95% CI 0·76–0·87), respectively. Our data highlight that the risk of non-immune travellers acquiring dengue in Thailand is substantial. The incidence of 0·81% after a 1-month stay is similar to that reported in prospective seroconversion studies in Israeli travellers to Thailand, highlighting that our models are consistent with actual data. Risk estimates based on mathematical modelling offer more detailed information depending on various travel scenarios, and will help the travel medicine provider give better evidence-based advice for travellers to dengue-endemic countries.
format Online
Article
Text
id pubmed-3539241
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-35392412013-01-22 Dengue infections in non-immune travellers to Thailand MASSAD, E. ROCKLOV, J. WILDER-SMITH, A. Epidemiol Infect Original Papers Dengue is the most frequent arboviral disease and is expanding geographically. Dengue is also increasingly being reported in travellers, in particular in travellers to Thailand. However, data to quantify the risk of travellers acquiring dengue when travelling to Thailand are lacking. Using mathematical modelling, we set out to estimate the risk of non-immune persons acquiring dengue when travelling to Thailand. The model is deterministic with stochastic parameters and assumes a Poisson distribution for the mosquitoes' biting rate and a Gamma distribution for the probability of acquiring dengue from an infected mosquito. From the force of infection we calculated the risk of dengue acquisition for travellers to Thailand arriving in a typical year (averaged over a 17-year period) in the high season of transmission. A traveller arriving in the high season of transmission and remaining for 7 days has a risk of acquiring dengue of 0·2% (95% CI 0·16–0·23), whereas the risk for travel of 15 and 30 days' duration is 0·46% (95% CI 0·41–0·50) and 0·81% (95% CI 0·76–0·87), respectively. Our data highlight that the risk of non-immune travellers acquiring dengue in Thailand is substantial. The incidence of 0·81% after a 1-month stay is similar to that reported in prospective seroconversion studies in Israeli travellers to Thailand, highlighting that our models are consistent with actual data. Risk estimates based on mathematical modelling offer more detailed information depending on various travel scenarios, and will help the travel medicine provider give better evidence-based advice for travellers to dengue-endemic countries. Cambridge University Press 2013-02 2012-05-03 /pmc/articles/PMC3539241/ /pubmed/22651899 http://dx.doi.org/10.1017/S0950268812000507 Text en © Cambridge University Press 2012 https://creativecommons.org/licenses/by-nc-sa/2.5/The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ (https://creativecommons.org/licenses/by-nc-sa/2.5/) >. The written permission of Cambridge University Press must be obtained for commercial re-use.
spellingShingle Original Papers
MASSAD, E.
ROCKLOV, J.
WILDER-SMITH, A.
Dengue infections in non-immune travellers to Thailand
title Dengue infections in non-immune travellers to Thailand
title_full Dengue infections in non-immune travellers to Thailand
title_fullStr Dengue infections in non-immune travellers to Thailand
title_full_unstemmed Dengue infections in non-immune travellers to Thailand
title_short Dengue infections in non-immune travellers to Thailand
title_sort dengue infections in non-immune travellers to thailand
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539241/
https://www.ncbi.nlm.nih.gov/pubmed/22651899
http://dx.doi.org/10.1017/S0950268812000507
work_keys_str_mv AT massade dengueinfectionsinnonimmunetravellerstothailand
AT rocklovj dengueinfectionsinnonimmunetravellerstothailand
AT wildersmitha dengueinfectionsinnonimmunetravellerstothailand